Adaptimmune Therapeutics Plc
Adaptimmune is a clinical-stage biopharmaceutical company dedicated to revolutionizing cancer treatment through innovative cell therapy. By harnessing the power of a patient's own cells, Adaptimmune aims to create personalized therapies that specifically target and combat solid tumors.
Founded: 3 Dec 2014
Industries:
72110 - Research and experimental development on biotechnology
Website: adaptimmune.com
Phone: +441235430000
Email: dana.lynch@adaptimmune.com
Location: Abingdon
Products & Services
• afami-cel
• cancer immunotherapy
• cell therapy
• lete-cel
• personalized cell therapy development
• research and product development
• solid tumors
• uza-cel
Financial Snapshot
Cash in Bank
Turnover
EBITDA
Gross Profit
Total Liabilities
Employees
Unlock financial data with Pro Start Free Trial →
People
Officers
9
Shareholders
1
Controllers (PSC)
0
Ali Behbahani
Director • American • Lives in United States • Born in Dec 1976
Andrew Roger Allen
Director • British • Lives in United States • Born in May 1966
David Morrell Mott
Director • American • Lives in United States • Born in Sept 1965
Lawrence Michael Alleva
Director • American • Lives in United States • Born in Oct 1949
John Paul Furey
Director • Irish • Lives in United States • Born in May 1964
Basic Information
PLC
3 Dec 2014
ENGLAND WALES
Yes
Industry Classification
72110
Company Attributes
N/A
N/A
N/A
N/A
Summary
19
Officers
0
PSCs
0
Filings